Clinical Trial Update: PC001- A Study to Evaluate the Usability of PointCheck [NA]

View source ↗

Summary

The PC001 usability study for PointCheck conducted by Leuko Labs has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Neutropenia

Snippet

Sponsor: Leuko Labs, Inc. | Conditions: Neoplasms, Neutropenia | NA | Status: COMPLETED